Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

IND filing for phase I/II AVENGE trial of EW-A-401

Feb. 13, 2004

New phase II trial studies effects of ALT-711 on endothelial function

Feb. 13, 2004

Improved efficacy of antianginal drugs after coadministration with ranolazine

Feb. 12, 2004

Enrollment under way in ARRIVE registry program

Feb. 10, 2004

NNC-55-0396: A novel selective T-type Ca2+ channel inhibitor

Feb. 10, 2004

Sanofi-Synthelabo acquires Taisho's stake in Japanese joint venture

Feb. 6, 2004

Caduet receives FDA approval

Feb. 5, 2004

sNDA for intravenous administration of Remodulin

Feb. 4, 2004

CE Mark for Celacade for chronic heart failure

Feb. 4, 2004

Novartis files global applications for new Diovan indication

Feb. 4, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...